< Back to previous page
Researcher
Maarten Lambrecht
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Department of Oncology (Department)
Member
From1 Oct 2017 → 20 Dec 2018 - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2010 → Today
Projects
1 - 10 of 11
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- To cure is to live: reducing cardiac impact of modern breast cancer radiotherapy.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Advanced brain imaging in radiation-induced changes after novel radiotherapy techniquesFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards cost-effective patient selection for proton therapy in thoracic cancers: a framework for continuously updating prediction modelsFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Implementation of AI-based contouring and treatment planning for daily personalized RT treatments for lung cancerFrom1 Jun 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Self-management of symptom clusters in (ex-) breast, prostate and lung cancer patients treated with radiotherapy: development of a care trajectory.From1 Jan 2022 → 31 Aug 2022Funding: Foundations, funds and other with scientific goal
- Neurocognition-sparing radiotherapy of brain and base of skull tumours: modelling toxicity and probing dose-dependent alterations in the brain using advanced imaging techniques.From18 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Exploring strategies to reduce toxicity in the multimodal treatment of esophageal cancerFrom1 Jun 2017 → 31 May 2021Funding: Nonprofit institution or equivalents
- Exploring strategies to reduce toxicity in the multimodal treatment of oesophageal cancerFrom1 Aug 2016 → 9 Nov 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
11 - 20 of 105
- Health-related quality of life in the randomised ARTFORCE PET-Boost trial in locally-advanced NSCLC(2023)
Authors: Maarten Lambrecht
Pages: S116 - S117 - Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations(2023)
Authors: Maarten Lambrecht
Pages: S205 - S207 - Do patients with lung cancer and a genetic risk for rheumatoid arthritis have increased toxicity?(2023)
Authors: Maarten Lambrecht
Pages: S492 - S493 - NTCP Models for Late Tissue Fibrosis Following Breast RT are Validated in a Large Prospective Cohort(2023)
Authors: Maarten Lambrecht
Pages: S23 - S24 - Reconstructing dose distributions from manually planned electron boosts in breast radiotherapy(2023)
Authors: Maarten Lambrecht
Pages: S1798 - S1800 - Variation in incidental dose to the axilla in patients treated with whole breast radiotherapy alone(2023)
Authors: Maarten Lambrecht
Pages: S170 - S171 - Pattern of brain metastases after HA-PCI and SRCF in SCLC: pooled findings of NCT01780675 and PREMER(2023)
Authors: Maarten Lambrecht
Pages: S490 - S492 - Genetically-based Cox-NTCP models for late toxicity after prostate cancer RT(2023)
Authors: Maarten Lambrecht
Pages: S418 - S420 - Lungtech EORTC 22113-08113 prospective multicenter trial: SBRT for central lung tumors(2023)
Authors: Maarten Lambrecht
Pages: S495 - S497 - 18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial(2023)
Authors: Maarten Lambrecht